Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

Blood

Volumn 97, Issue 1, 2001, Pages 89-94

  Meshinchi, Soheil ^a   Woods, William G ^b   Stirewalt, Derek L ^b   Sweetser, David A ^b   Buckley, Jonathan D ^b   Tjoa, Thomas K ^b   Bernstein, Irwin D ^b   Radich, Jerald P ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER SURVIVAL; CHROMOSOME 13; GENE DUPLICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RISK FACTOR; TREATMENT OUTCOME;

EID: 0035168677     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.1.89     Document Type: Article

References (23)

1. c-kit ligand and Flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities
2. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs
3. Characterization of the protein encoded by the flt3(flk2) receptor-like tyrosine kinase gene
4. Flt3 ligand stimutales proliferation and inhibits apoptosis of acute myeloid leukemia cells: Regulation of Bcl-2 and Bax
5. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia
6. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies: A study on a large series of patients and cell lines
7. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product
8. Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells
9. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia
10. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia
11. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
12. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene
13. Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia
14. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Childrens Cancer Group pilot study
15. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group
16. Treatment of acute myeloid leukemia
17. p73 mutations and expression in adult de novo acute myelogenous leukemia
18. Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR
19. Nonparametric estimation from incomplete observations
20. Regression models and life-tables (with discussion)
21. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines
22. Mechanisms of constitutive activation of c-kit receptor tyrosine kinase
23. Clinical efficacy and safety of an ABL specific kinase inhibitor as targeted therapy for chronic myelogenous leukemia